CMTA-STAR Awards $1.1 Million for CMT1X, CMT2A Clinical Trials
…March 23 aimed at helping top CMT scientists prepare for clinical trials for CMT1X and CMT2A. CMT is a degenerative neuromuscular disease that kills the long, or peripheral, nerves to…
Welcome to the Walk4CMT Toolbox
Welcome to the Walk4CMT Toolbox We are grateful that you have taken on a Walk 4 CMT event! This timeline will help you organize and promote your event, give you…
CMT_Survivors_Guide
Preguntas Frecuentes
…Tooth. ¿Hay algún tratamiento para CMT? No hay tratamientos conocidos que detenga o disminuya la progresión del CMT, pero la CMTA está financiando investigaciones para encontrar tratamientos. La terapia física,…
Wilmington, NC CMTA Branch Meeting (In-Person) with Guest Speaker
05/04/2024 @ 10:00 am – 12:00 pm – Please join us for a CMT get-together on Saturday, May 4 from 10 am – 12 pm at the Northeast Library near Landfall Country Club (see library address below). This will be a fun get together combining a bit of education and a bit of social time. We will welcome special guest speaker, Kelsey Komyathy, […]
CMTA Spring 2024 Report: Progress and Impact that Empowers Communities
The 2024 Spring CMTA Report (1474 downloads ) VIEW IN BROWSER Sue Bruhn, the CEO of CMTA, expresses gratitude and excitement for the upcoming year and highlights the achievements and…
CMTA Announces New Center of Excellence at Virginia Commonwealth University
The Charcot-Marie-Tooth Association (CMTA), the world’s largest philanthropic funder of research aimed at bringing treatments to patients and improving the lives of those living with Charcot-Marie-Tooth disease (CMT), is proud…
2020_CMT_PFC_Pediatric_Neurology_transcript
The Summer 2021 CMTA Report
…Grants to Researchers Prepping for CMT1X, CMT2A Clinical Trials Interim Analysis Shows Sustained Benefits of PXT3003 for CMT1A Patients Seeking Participants for Biomarker Study It’s Time to Dance 4 CMT!…
Gene Therapy Advances for CMT4J, CMT4A and GAN
…CMT, Giant Axonal Neuropathy (GAN), CMT4J, and CMT4A. The treatment for GAN has been in human clinical trials since 2015, the work for CMT4J is moving toward a human clinical…